These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 687477)

  • 21. [Méxiletine. Action on heart rhythm disorders].
    Lellouche D; Bougherbal R
    Nouv Presse Med; 1975 Feb; 4(5):351-2. PubMed ID: 1093125
    [No Abstract]   [Full Text] [Related]  

  • 22. Mexiletine therapy in patients with chronic drug-resistant malignant ventricular arrhythmias. Clinical efficacy, safety, and side effects.
    Haggman DL; Maloney JD; Morant VA; Castle LW; King-Rankine M; Goormastic M
    Cleve Clin Q; 1986; 53(2):171-9. PubMed ID: 2874902
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral mexiletine in the treatment of refractory ventricular arrhythmias: the role of electrophysiologic techniques.
    Schoenfeld MH; Whitford E; McGovern B; Garan H; Ruskin JN
    Am Heart J; 1984 May; 107(5 Pt 2):1071-8. PubMed ID: 6372423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of mexiletine and a slow release formulation of mexiletine in patients admitted to a coronary care unit [proceedings].
    Boyle DM; Chapman C; Kinney C; McIlmoyle EL; Salathia K; Shanks RG
    Br J Clin Pharmacol; 1980 Mar; 9(3):293P. PubMed ID: 7362748
    [No Abstract]   [Full Text] [Related]  

  • 25. Antiarrhythmic plasma concentrations of mexiletine on canine ventricular arrhythmias.
    Hashimoto K; Ishii M; Komori S
    J Cardiovasc Pharmacol; 1984; 6(2):213-9. PubMed ID: 6200706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mexiletine for recurring ventricular arrhythmias: assessment by long-term electrocardiographic recordings and sequential electrophysiologic studies.
    Flaker GC; Madigan NP; Alpert MA; Moser SA
    Am Heart J; 1984 Sep; 108(3 Pt 1):490-5. PubMed ID: 6475711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mexiletine in refractory ventricular arrhythmias.
    Fenster PE; Kern KB
    Clin Pharmacol Ther; 1983 Dec; 34(6):777-84. PubMed ID: 6641093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and the antiarrhythmic effect of mexiletine in patients with chronic ventricular arrhythmias.
    Ohashi K; Ebihara A; Hashimoto T; Hosoda S; Kondo K; Oka T
    Arzneimittelforschung; 1984; 34(4):503-7. PubMed ID: 6540110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of mexiletine and lidocaine on myocardial performance in heart disease patients in various functional classes].
    Chiariello M; Ferro G; Santinelli V; Tari MG; Condorelli M
    Boll Soc Ital Cardiol; 1978; 23(6):1006-14. PubMed ID: 261866
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antiarrhythmic treatment with mexiletine in acute myocardial infarction (author's transl)].
    Codecà L; Gruppillo P; Padovan GC; Masoni C; Masoni A
    G Ital Cardiol; 1981; 11(4):477-80. PubMed ID: 7286520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mexiletine for refractory-ventricular arrhythmias: results using serial electrophysiologic testing.
    DiMarco JP; Garan H; Ruskin JN
    Am J Cardiol; 1981 Jan; 47(1):131-8. PubMed ID: 7457398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study to compare the efficacy, plasma concentration profile and tolerability of conventional mexiletine and slow-release mexiletine.
    Upward JW; Holt DW; Jackson G
    Eur Heart J; 1984 Mar; 5(3):247-52. PubMed ID: 6723694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mexitil in the treatment of arrhythmia].
    Modlińska J
    Wiad Lek; 1984 Jan; 37(2):133-5. PubMed ID: 6380116
    [No Abstract]   [Full Text] [Related]  

  • 35. [Mexiletine, a new anti-arrhythmic, in the treatment of ventricular arrhythmia].
    Menozzi C; Brignole M; Monducci I; Lolli G; Vergoni W; Guiducci U; Bertulla A
    Clin Ter; 1982 Jan; 100(2):175-88. PubMed ID: 7186423
    [No Abstract]   [Full Text] [Related]  

  • 36. The development of mexiletine in the treatment of cardiac arrhythmias.
    Nimmo J
    Postgrad Med J; 1977; 53 Suppl 1():120-3. PubMed ID: 876943
    [No Abstract]   [Full Text] [Related]  

  • 37. [Short-and long-term therapy with Mexitil].
    Esser H; Kikis D
    Adv Clin Pharmacol; 1978; 16():169-86. PubMed ID: 356552
    [No Abstract]   [Full Text] [Related]  

  • 38. A trial of prophylactic mexiletine in home coronary care.
    Bell JA; Thomas JM; Isaacson JR; Snell NJ; Holt DW
    Br Heart J; 1982 Sep; 48(3):285-90. PubMed ID: 7049204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study of the antiarrhythmic efficacy of mexiletine and disopyramide in patients with chronic ventricular arrhythmias.
    Breithardt G; Seipel L; Lersmacher J; Abendroth RR
    J Cardiovasc Pharmacol; 1982; 4(2):276-84. PubMed ID: 6175812
    [No Abstract]   [Full Text] [Related]  

  • 40. Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial.
    Trimarco B; Volpe M; Ricciardelli B; Sacca' L; De Luca N; Rengo F; Condorelli M
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):251-9. PubMed ID: 7013721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.